At last week’s Genitourinary Cancers Symposium, Amini et al. presented the results of a data analysis that addresses the question of which kind of high-dose radiation therapy has the best cancer control rates … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: boost, brachytherapy, high-dose, radiation, therapy, very high-dose | 2 Comments »
A new report from Memorial Sloan-Kettering Cancer Center has documented patient outcomes at 10 years after high-dose, intensity-modulated radiation therapy (IMRT) for men initially diagnosed with clinically localized prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: high-dose, IMRT, intensity-modulated radtiation therapy, localized, outcome | 2 Comments »
ACR 03-12 is a Phase II clinical trial designed by the American College of Radiology to test the safety and efficacy of 82 GyE (Gray equivalent) delivered using conformal proton beam radiation therapy (PBRT) for the treatment of localized prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: high-dose, PBRT, proton beam radiation therapy, toxicity | 2 Comments »
Historically there have been few really compelling data available to support the use of an additional or alternative antiandrogen as a second-line agent to extend either progression-free or overall survival of castration-resistant prostate cancer (CRPC) patients who progress after first-line hormone therapy (whether they have been treated by orchiectomy or medical castration with an LHRH agonist). … READ MORE …
Filed under: Management, Treatment | Tagged: antiandrogen, bicalutamide, high-dose, hormone, second-line, therapy | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 